Keep on Keeping on – Mirena IUD for 8 Years

References

1. 1.↵
   1. Jensen JT,
   2. Lukkari-Lax E,
   3. Schulze A,
   4. et al

   . Contraceptive efficacy and safety of the 52-mg levonorgestrel intrauterine system for up to 8 years: findings from the Mirena Extension Trial. Am J Obstet Gynecol 2022;227:873.e1–873.e12.

   OpenUrlPubMed
2. 2.↵
   1. Hatcher RA

   et al. eds. Contraceptive technology. 21st ed. Atlanta: Managing Contraception, LLC; 2018.
3. 3.↵
   1. Lesnewski R,
   2. Prine L,
   3. Ginzburg R

   . Preventing gaps when switching contraceptives. Am Fam Physician 2011;83:567–70.

   OpenUrlPubMed
4. 4.↵
   1. Bajos N,
   2. Lamarche-Vadel A,
   3. Gilbert F

   , COCON Groupet al. Contraception at the time of abortion: high-risk time or high-risk women? Hum Reprod 2006;21:2862–7.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Buhling KJ,
   2. Zite NB,
   3. Lotke P,
   4. Black K

   , INTRA Writing Group. Worldwide use of intrauterine contraception: a review. Contraception 2014;89:162–73.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Smith P,
   2. Castelli G

   . The priority updates from the research literature (PURLs) Methodology. J Am Board Fam Med 2024;37:799–802.

   OpenUrlFREE Full Text
7. 7.
   1. Wu JP,
   2. Pickle S

   . Extended use of the intrauterine device: a literature review and recommendations for clinical practice. Contraception 2014;89:495–503.

   OpenUrlPubMed
8. 8.↵
   1. Andersson K,
   2. Odlind V,
   3. Rybo G

   . Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial. Contraception 1994;49:56–72.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Teal SB,
   2. Turok DK,
   3. Chen BA,
   4. Kimble T,
   5. Olariu AI,
   6. Creinin MD

   . Five-year contraceptive efficacy and safety of a levonorgestrel 52-mg intrauterine system. Obstet Gynecol 2019;133:63–70.

   OpenUrlPubMed
10. 10.↵
    1. Costescu D,
    2. Chawla R,
    3. Hughes R,
    4. et al

    . Discontinuation rates of intrauterine contraception due to unfavourable bleeding: a systematic review. BMC Womens Health 2022;22:82.

    OpenUrlPubMed
11. 11.↵
    1. Creinin MD,
    2. Schreiber CA,
    3. Turok DK,
    4. Cwiak C,
    5. Chen BA,
    6. Olariu AI

    . Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use. Am J Obstet Gynecol 2022;227:871.e1–871.e7.

    OpenUrlCrossRefPubMed